Question: why amneal stock is down?
Answer: Unhappily, Amneal Pharmaceuticals had to report a 1566% decline in EPS over the last year. This was, in part, due to extraordinary items impacting earnings. In fact, it actually made a loss over the last twelve months. The share price fall of 75% isn't as bad as the reduction in earnings per share.